Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Podcasts
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Podcasts
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 74, Issue 11
Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort study
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Clinical and epidemiological research
Extended report
Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort study
Online download statistics by month:
Online download statistics by month: June 2014 to March 2024
Abstract
Full
Pdf
Jun 2014
415
53
88
Jul 2014
116
34
34
Aug 2014
63
21
27
Sep 2014
58
24
22
Oct 2014
34
32
27
Nov 2014
48
17
18
Dec 2014
22
16
11
Jan 2015
53
14
21
Feb 2015
36
16
18
Mar 2015
42
26
21
Apr 2015
20
20
16
May 2015
15
12
7
Jun 2015
23
18
18
Jul 2015
33
17
18
Aug 2015
36
11
13
Sep 2015
62
25
28
Oct 2015
1023
37
106
Nov 2015
1014
86
149
Dec 2015
353
25
38
Jan 2016
260
31
31
Feb 2016
147
24
23
Mar 2016
161
16
27
Apr 2016
86
12
18
May 2016
111
15
50
Jun 2016
103
19
14
Jul 2016
64
7
10
Aug 2016
74
20
16
Sep 2016
89
10
9
Oct 2016
74
20
19
Nov 2016
76
8
6
Dec 2016
43
9
7
Jan 2017
72
10
13
Feb 2017
46
20
15
Mar 2017
37
10
11
Apr 2017
31
7
5
May 2017
34
14
15
Jun 2017
80
16
13
Jul 2017
90
3
12
Aug 2017
80
7
11
Sep 2017
112
5
10
Oct 2017
94
7
7
Nov 2017
107
4
5
Dec 2017
76
1
4
Jan 2018
92
8
4
Feb 2018
76
7
7
Mar 2018
120
26
18
Apr 2018
155
33
15
May 2018
166
36
19
Jun 2018
141
31
9
Jul 2018
147
36
7
Aug 2018
107
25
4
Sep 2018
93
20
5
Oct 2018
97
22
5
Nov 2018
41
7
6
Dec 2018
57
9
3
Jan 2019
81
16
6
Feb 2019
50
7
0
Mar 2019
103
14
3
Apr 2019
82
23
5
May 2019
64
16
4
Jun 2019
89
19
8
Jul 2019
75
23
3
Aug 2019
55
13
3
Sep 2019
74
13
6
Oct 2019
62
15
4
Nov 2019
53
15
3
Dec 2019
99
12
4
Jan 2020
97
19
6
Feb 2020
54
11
5
Mar 2020
23
1
1
Apr 2020
43
2
2
May 2020
38
7
4
Jun 2020
48
2
3
Jul 2020
51
10
2
Aug 2020
35
3
6
Sep 2020
73
4
2
Oct 2020
61
3
0
Nov 2020
50
7
1
Dec 2020
53
4
3
Jan 2021
80
9
7
Feb 2021
78
8
7
Mar 2021
57
9
3
Apr 2021
53
4
1
May 2021
38
2
1
Jun 2021
5
2
2
Jul 2021
9
3
2
Aug 2021
8
6
4
Sep 2021
11
7
0
Oct 2021
69
4
0
Nov 2021
65
7
1
Dec 2021
54
5
2
Jan 2022
41
2
0
Feb 2022
58
4
0
Mar 2022
121
4
1
Apr 2022
89
5
0
May 2022
137
9
4
Jun 2022
123
3
0
Jul 2022
83
18
3
Aug 2022
73
6
3
Sep 2022
118
6
5
Oct 2022
106
4
2
Nov 2022
73
3
3
Dec 2022
41
3
2
Jan 2023
85
4
4
Feb 2023
124
5
4
Mar 2023
91
8
5
Apr 2023
34
3
0
May 2023
133
9
3
Jun 2023
99
11
5
Jul 2023
31
1
2
Aug 2023
28
2
1
Sep 2023
46
8
5
Oct 2023
60
3
1
Nov 2023
47
3
0
Dec 2023
104
3
3
Jan 2024
265
9
5
Feb 2024
105
6
3
Mar 2024
131
6
4
Total
11391
1532
1315
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF